Response letter to the article: recurrent femur neck fracture and response to bisphosphonates in polyostotic fibrous dysplasia: a novel molecular mechanism.
Hamid
H
Namazi
D050071:Bone Density Conservation Agents / Q000627:therapeutic use*; D004164:Diphosphonates / Q000627:therapeutic use*; D005260:Female; D005265:Femoral Neck Fractures / Q000209:etiology*; D005359:Fibrous Dysplasia, Polyostotic / Q000188:drug therapy*; D006801:Humans
D050071:Bone Density Conservation Agents; D004164:Diphosphonates